This is well illustrated by the caveats in cannabinoid ligand development – brain-penetrant CB1R inverse antagonist proved to be potent anti-obesity drugs (37) but exerted serious psychiatric side effects and had to be eventually withdrawn (38, 39). Here, CNR1 is linked to Obesity.